Zydus gets FDA approval for risperidone tablets
This article was originally published in Scrip
Executive Summary
Zydus Cadilahas received approval from the US FDAto market risperidone tablets 0.25mg, 0.5mg, 1mg, 2mg, 3mg and 4mg, generic versions of Janssen's treatment for schizophrenia, Risperdal tablets. Estimated sales of risperidone were $2.1 billion last year. Zydus has received 41 FDA approvals and filed 79 ANDAs so far.